Cargando…

Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand

Royal jelly is a nutritious substance produced by the hypopharyngeal and mandibular glands of honeybees. Royal jelly possesses many attractive and beneficial properties which make it an ideal component in medical and pharmaceutical products. The antibacterial, antioxidant, and anti-inflammatory acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Uthaibutra, Vitchayaporn, Kaewkod, Thida, Prapawilai, Pichet, Pandith, Hataichanok, Tragoolpua, Yingmanee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920569/
https://www.ncbi.nlm.nih.gov/pubmed/36770665
http://dx.doi.org/10.3390/molecules28030996
_version_ 1784887102536679424
author Uthaibutra, Vitchayaporn
Kaewkod, Thida
Prapawilai, Pichet
Pandith, Hataichanok
Tragoolpua, Yingmanee
author_facet Uthaibutra, Vitchayaporn
Kaewkod, Thida
Prapawilai, Pichet
Pandith, Hataichanok
Tragoolpua, Yingmanee
author_sort Uthaibutra, Vitchayaporn
collection PubMed
description Royal jelly is a nutritious substance produced by the hypopharyngeal and mandibular glands of honeybees. Royal jelly possesses many attractive and beneficial properties which make it an ideal component in medical and pharmaceutical products. The antibacterial, antioxidant, and anti-inflammatory activities of royal jelly from honeybees (Apis mellifera) were determined in this study. Moreover, the total phenolic and flavonoid contents of the royal jelly were also evaluated. The effects of royal jelly on growth inhibition against skin pathogenic bacteria, including Cutibacterium acnes, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, and Corynebacterium spp., were investigated by the agar well diffusion method. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were further determined by the broth dilution method. The results indicated that royal jelly showed antibacterial activity by inhibiting the growth of Gram-positive pathogenic bacteria, while the effectiveness decreased against Gram-negative bacteria. Interestingly, royal jelly from Lamphun (RJ-LP1), and Chiang Mai (RJ-CM1), presented high inhibitory efficacy against C. acnes, MRSA, and S. aureus within 4 h by a time killing assay. Furthermore, the anti-inflammatory properties of royal jelly were tested using RAW264.7 macrophage cells, and results revealed that RJ-LP1 and RJ-CM1 could reduce nitric oxide (NO) production and suppress iNOS gene expression. After testing the antioxidant activity, RJ-CM1 and RJ-CM2 of royal jelly from Chiang Mai had the highest level. Additionally, RJ-CM1 also showed the highest total phenolic and flavonoid content. These findings have brought forward new knowledge of the antibacterial, antioxidant, and anti-inflammatory properties of royal jelly, which will improve clinical and pharmaceutical uses of royal jelly as an alternative therapy for bacterial infections, and also as a dietary supplement product.
format Online
Article
Text
id pubmed-9920569
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99205692023-02-12 Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand Uthaibutra, Vitchayaporn Kaewkod, Thida Prapawilai, Pichet Pandith, Hataichanok Tragoolpua, Yingmanee Molecules Article Royal jelly is a nutritious substance produced by the hypopharyngeal and mandibular glands of honeybees. Royal jelly possesses many attractive and beneficial properties which make it an ideal component in medical and pharmaceutical products. The antibacterial, antioxidant, and anti-inflammatory activities of royal jelly from honeybees (Apis mellifera) were determined in this study. Moreover, the total phenolic and flavonoid contents of the royal jelly were also evaluated. The effects of royal jelly on growth inhibition against skin pathogenic bacteria, including Cutibacterium acnes, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, and Corynebacterium spp., were investigated by the agar well diffusion method. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were further determined by the broth dilution method. The results indicated that royal jelly showed antibacterial activity by inhibiting the growth of Gram-positive pathogenic bacteria, while the effectiveness decreased against Gram-negative bacteria. Interestingly, royal jelly from Lamphun (RJ-LP1), and Chiang Mai (RJ-CM1), presented high inhibitory efficacy against C. acnes, MRSA, and S. aureus within 4 h by a time killing assay. Furthermore, the anti-inflammatory properties of royal jelly were tested using RAW264.7 macrophage cells, and results revealed that RJ-LP1 and RJ-CM1 could reduce nitric oxide (NO) production and suppress iNOS gene expression. After testing the antioxidant activity, RJ-CM1 and RJ-CM2 of royal jelly from Chiang Mai had the highest level. Additionally, RJ-CM1 also showed the highest total phenolic and flavonoid content. These findings have brought forward new knowledge of the antibacterial, antioxidant, and anti-inflammatory properties of royal jelly, which will improve clinical and pharmaceutical uses of royal jelly as an alternative therapy for bacterial infections, and also as a dietary supplement product. MDPI 2023-01-19 /pmc/articles/PMC9920569/ /pubmed/36770665 http://dx.doi.org/10.3390/molecules28030996 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Uthaibutra, Vitchayaporn
Kaewkod, Thida
Prapawilai, Pichet
Pandith, Hataichanok
Tragoolpua, Yingmanee
Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand
title Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand
title_full Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand
title_fullStr Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand
title_full_unstemmed Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand
title_short Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand
title_sort inhibition of skin pathogenic bacteria, antioxidant and anti-inflammatory activity of royal jelly from northern thailand
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920569/
https://www.ncbi.nlm.nih.gov/pubmed/36770665
http://dx.doi.org/10.3390/molecules28030996
work_keys_str_mv AT uthaibutravitchayaporn inhibitionofskinpathogenicbacteriaantioxidantandantiinflammatoryactivityofroyaljellyfromnorthernthailand
AT kaewkodthida inhibitionofskinpathogenicbacteriaantioxidantandantiinflammatoryactivityofroyaljellyfromnorthernthailand
AT prapawilaipichet inhibitionofskinpathogenicbacteriaantioxidantandantiinflammatoryactivityofroyaljellyfromnorthernthailand
AT pandithhataichanok inhibitionofskinpathogenicbacteriaantioxidantandantiinflammatoryactivityofroyaljellyfromnorthernthailand
AT tragoolpuayingmanee inhibitionofskinpathogenicbacteriaantioxidantandantiinflammatoryactivityofroyaljellyfromnorthernthailand